Thai Healthcare Company Forays Into India (Thailand)
This article was originally published in PharmAsia News
One of Thailand's leading health care companies, Megal Lifesciences, announced it would begin marketing skincare medications in India on Nov. 15. The company will launch its Glow and Pynocare lines starting in the National Capital Region of the country and later moving to other cities. The product will be available at all drug stores. All of the drugs will be imported from Megal's manufacturing facilities in Bangkok and Melbourne. If the new marketing push is successful, company representatives say Megal would also consider expanding manufacturing operations to India. (Click here for more
You may also be interested in...
Chugai is pursuing further Japanese litigation over generic rivals to its Edirol brand, this time concerning the eldecalcitol ingredient produced by Nissan Chemical.
The European Commission has unexpectedly concluded that CBD should not be considered as a drug opening up the path to a regulated EU market for the cannabinoid as a novel food.
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.